CoChat

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

Open access
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., Attia, J. · 2009 · International Journal of Andrology
Cited by 124

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: The aim of this study was to determine the prevalence and investigate the aetiology of hypogonadism in men on methadone or buprenorphine maintenance treatment (MMT, BMT). 103 men (mean age 37.6 ± 7.9) on MMT (n = 84) or BMT (n = 19) were evaluated using hormone assays, body mass index (BMI), serological, biochemical, demographic and substance use measures. Overall 54% of men (methadone 65%; buprenorphine 28%) had total testosterone (TT) <12.0 n m; 34% (methadone 39%; buprenorphine 11%) had TT <8.0 n m. Both methadone‐ and buprenorphine‐treated men had lower free testosterone, luteinising hormone and estradiol than age‐matched reference groups. Methadone‐treated men had lower TT than buprenorphine‐treated men and reference groups. Prolactin did not differ between methadone, buprenorphine groups, and reference groups. Primary testicular failure was an uncommon cause of hypogonadism. Yearly percentage fall in TT by age across the patient group was 2.3%, more than twice that expected normally. There were no associations between TT and opioid dose, cannabis, alcohol and tobacco consumption, or chronic hepatitis C viraemia. On multiple regression higher TT was associated with higher alanine aminotransferase and lower TT with higher BMI. Men on MMT have high prevalence of hypogonadotrophic hypogonadism. The extent of hormonal changes associated with buprenorphine needs to be explored further in larger studies. Men receiving long term opioid replacement treatment, especially methadone treatment, should be screened for hypogonadism. Wide interindividual differences in methadone metabolism and tolerance may in a cross‐sectional study obscure a methadone dose relationship to testosterone in individuals. Future studies of hypogonadism in opioid‐treated men should examine the potential benefits of dose reduction, choice of opioid medication, weight loss, and androgen replacement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2605.2007.00824.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 124

Metadata

Authors
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., & Attia, J.
Venue
International Journal of Andrology
Publisher
Wiley
Published
2009-03-03
Volume
32
Issue
2
Pages
131-139
ISSN
  • 0105-6263 (ISSN-L)
  • 1365-2605
OpenAlex
W2023768553
Cited by
124
References
4
FWCI
2.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. https://app.cochat.ai/papers/10.1111/j.1365-2605.2007.00824.x
The paper
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., & Attia, J. (2009). Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. International Journal of Andrology. https://doi.org/10.1111/j.1365-2605.2007.00824.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.